Early mistakes in testing, aging data systems, clashes with President Trump and an overly cautious culture shook confidence in the nation’s premier public health agency.
from Health https://ift.tt/2XpXurI
June 03, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid TrialOklahoma pursued the first case against a drug manufacturer for the national public health disaster, and the ruling may point to what lies ahead in 2,000 more lawsuits. from Health https://ift.tt/2LnqfhN … Read More
The Great Fortune of Ordinary SadnessTo be a parent in America now is to carry both the mundane, expected grief of letting children go and the fear of far more tragic loss. from Health https://ift.tt/2L3FoG3 … Read More
How to Help Teenagers Keep Track of Their StuffExpert advice on how to make sure all those new back-to-school jackets, water bottles and backpacks make it back from school. from Health https://ift.tt/2Zyd2aH … Read More
Surfing With a DisabilitySeveral nonprofit groups cater to surfers with disabilities, both physical and cognitive. from Health https://ift.tt/2L1Biy4 … Read More
Why Was Johnson & Johnson the Only Opioid Maker on Trial in Oklahoma?Other states are suing a range of drug makers, distributors and retailers. Here are three reasons Johnson & Johnson was the only company on trial in Oklahoma. from Health https://ift.tt/2ZBI0Da … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment